Interview with MBBP Client Valeritas Included in Wall Street Transcript Medical Devices Report

The most recent Wall Street Transcript Medical Devices Report includes an interview with Valeritas, Inc.'s CEO, John Timberlake.  Timberlake discusses in detail Valeritas's V-Go Disposable Insulin Delivery Device. The V-Go is a wearable basal-bolus insulin delivery device that allows patients to deliver insulin at a continuous preset basal rate, with bolus delivery as needed.  The V-Go …

Continue reading Interview with MBBP Client Valeritas Included in Wall Street Transcript Medical Devices Report

MBBP Client Valeritas, Inc. Announced Positive Results for V-Go® Disposable Insulin Delivery Device

MBBP client Valeritas, Inc. has recently announced positive results for four studies on their flagship product. Valeritas is a commercial-stage medical technology company focused on developing innovative solutions to improve health and quality of life of people with Type 2 diabetes. Their flagship product is the V-Go® Disposable Insulin Delivery Device which is a small, wearable, disposable insulin delivery solution for …

Continue reading MBBP Client Valeritas, Inc. Announced Positive Results for V-Go® Disposable Insulin Delivery Device

MBBP Client Valeritas Receives FDA 510(k) Clearance for Insulin Delivery Device

MBBP client Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, has gained clearance from the U.S. Food and Drug Administration on the company's V-Go Disposable Insulin Delivery Device for use with Novo Nordisk's NovoLog® for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing …

Continue reading MBBP Client Valeritas Receives FDA 510(k) Clearance for Insulin Delivery Device